Biohacker CRISPRs himself in attempt to get bigger muscles
By GMWatch,
GMWatch
| 12. 11. 2017
A CBS News story reports an attempt by the biohacker Josiah Zayner to genetically modify himself to have bigger muscles, using the CRISPR genome-editing tool.
It seems that Zayner tried to alter his DNA by injecting his forearm with a piece of DNA called a plasmid, containing the gene that codes for the Cas9 genome-editing protein and its guide RNA targeted to the myostatin gene. The myostatin protein encoded by this gene checks the growth of muscles so they don’t become out-of-proportion huge. Zayner’s aim is to disrupt the myostatin gene that blocks muscle growth so that his muscles get larger.
Zayner carried out this process using a CRISPR kit that is available to buy online. Presumably it’s the same one that his own company sells and that he hopes to profit from.
Zayner described to CBS his view of the future possibilities with CRISPR: "Do I wanna be big and muscly? Do I wanna – you know, my muscles have, like, high endurance? Do I want to have dark colour skin or light colour skin or whatever you want...
Related Articles
By Mike McIntire, The New York Times | 01.24.2026
Genetic researchers were seeking children for an ambitious, federally funded project to track brain development — a study that they told families could yield invaluable discoveries about DNA’s impact on behavior and disease.
They also promised that the children’s sensitive...
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Danny Finley, Bill of Health | 01.08.2026
The United States Food and Drug Administration (FDA) has a unique funding structure among federal scientific and health agencies. The industries it regulates fund nearly half of its budget. The agency charges companies a user fee for each application
...
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...